Yaying Zhou
Overview
Explore the profile of Yaying Zhou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
67
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peng J, Wu Z, Zhong H, Zhou Y, Wang L, Wang Y, et al.
Medicine (Baltimore)
. 2020 Sep;
99(38):e22041.
PMID: 32957323
Background: Qigong is a traditional Chinese exercise method for health care, keeping fit and getting rid of diseases. It has the advantages of simple operation and few side effects. Corona...
2.
Zhou J, Hu L, Zuo M, Zhou Y, Li G, Zhang X
Am J Clin Pathol
. 2019 Aug;
153(1):49-57.
PMID: 31433838
Objectives: Mantle cell lymphoma (MCL) is a mature B-cell lymphoma characterized by CCND1/IGH rearrangement. We reported a case of MCL harboring both CCND1/IGH and MYC/IGH rearrangements that also presented with...
3.
Fang A, Zhang Q, Fan H, Zhou Y, Yao Y, Zhang Y, et al.
Medchemcomm
. 2018 Aug;
8(8):1720-1726.
PMID: 30108883
Human lactate dehydrogenase A (LDHA) has been identified as a potential therapeutic target in the area of cancer metabolism. Herein, we report the discovery of novel LDHA inhibitors through docking-based...
4.
Zhou F, Zhou Y, Yang M, Wen J, Dong J, Tan W
Cancer Manag Res
. 2018 Mar;
10:447-464.
PMID: 29563835
Background: Circulating endothelial cells (CECs) and their subpopulations could be potential novel biomarkers for various malignancies. However, reliable enumerable methods are warranted to further improve their clinical utility. This study...
5.
Fang A, Luo H, Liu L, Fan H, Zhou Y, Yao Y, et al.
Bioorg Med Chem Lett
. 2017 Nov;
27(24):5450-5453.
PMID: 29150396
Overexpression of pyruvate dehydrogenase kinases (PDKs), especially PDK1 has been observed in a variety of cancers. Thus, targeting PDK1 offers an attractive opportunity for the development of cancer therapies. In...
6.
Zhou F, Zhou Y, Dong J, Tan W
Biomark Med
. 2017 Jun;
11(8):665-676.
PMID: 28597689
Angiogenesis contributes to the growth of solid tumors. Antiangiogenic agents are widely used in various cancers and considerable efforts have been made in the development of novel biomarkers that can...
7.
Wang L, Qin W, Zhou Y, Chen B, Zhao X, Zhao H, et al.
Sci Rep
. 2017 Apr;
7(1):991.
PMID: 28428640
Povidone-iodine (PVI) is principally used as an antimicrobial agent. It has been found that 0.5% PVI can attenuate congestion, edema and pain induced by pressure sores. Thus this study aimed...
8.
Ning J, Mo L, Yi B, Gu J, Lu K, Zhou Y, et al.
Anesthesiology
. 2016 Mar;
124(6):1360-71.
PMID: 27028466
Background: Severe blast limb trauma (BLT) induces distant multiple-organ injuries. In the current study, the authors determined whether whole-body hypothermia (WH) and its optimal duration (if any) afford protection to...